Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Ophidian Pharmaceuticals (OTC BB:OPHD.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider | Financials
Location
6320 Monona Drive, Suite 407
Madison, WI 53716
Phone: (608) 221-1192
Fax: (608) 277-2395
Employees (last reported count): 24
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 48%
·Over the last 6 months:
 · 2 insider buys; 20.0K shares (3.7% of insider shares)
·Institutional: 0% (0% of float)
(0 institutions)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Ophidian Pharmaceuticals, Inc. was engaged in the design, development and commercialization of cost effective therapeutic and diagnostic products for human and animal use, focusing principally on products for the prevention and treatment of infectious diseases, until May 2000, when, due to lack of financing, the Company took action to cease operations. The Company's workforce was reduced 80% by laying off research, development and operations personnel. Remaining management staff was retained to wind down clinical trial and manufacturing operations and to continue to seek potential partners having strategic interests in markets served by the Company's products. In August 2001, the Company completed a merger with Hemoxymed, Inc. The merged company will focus on Hemoxymed's proprietary therapeutic process for increasing tissue oxygenation. Diseases involving insufficient oxygen delivery, including chronic heart failure and emphysema, affect more than 100 million patients worldwide.
More from Market Guide: Expanded Business Description

Financial Summary
OPHD was engaged in the research and development of therapeutic and diagnostic products for human and animal use, with an emphasis on infectious diseases. In May 2000, the Company decided to cease operations. For the nine months ended 6/01, revenues totalled $0, down from $1.3 million. Net loss decreased 77% to $432 thousand. Revenues reflect the absence of sales from patents. Lower loss reflects a decrease in research and development costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]

Position
Peter Model, Ph.D., 67Chairman
Margaret Van Boldrik, Ph.D., 44VP Corp. Devel., Director
Susan Maynard, 50Sec.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:OPHD.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 5-June-2001
$0.25 
Recent Price$0.35 
52-Week High
on 5-Sep-2000
$1.50 
Beta-2.04 
Daily Volume (3-month avg)6,682 
Daily Volume (10-day avg)1,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-63.3%
52-Week Change
relative to S&P500
-50.7%
Share-Related Items
Market Capitalization$405.0K
Shares Outstanding1.16M
Float600.0K
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 8 on 20-Sep-1999
Per-Share Data
Book Value (mrq)$0.20 
Earnings (ttm)-$2.41 
Earnings (mrq)-$0.03 
Sales (ttm)$0.30 
Cash (mrq)$0.32 
Valuation Ratios
Price/Book (mrq)1.78 
Price/EarningsN/A 
Price/Sales (ttm)1.15 
Income Statements
Sales (ttm)$354.0K
EBITDA (ttm)-$2.60M
Income available to common (ttm)-$2.80M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsSep 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-97.76%
Return on Equity (ttm)-161.18%
Financial Strength
Current Ratio (mrq)2.68 
Debt/Equity (mrq)0 
Total Cash (mrq)$365.0K
Short Interest
As of 10-Nov-2000
Shares Short0 
Shares Short
(Prior Month)
0 
Daily Volume20.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.